Midatech Pharma PLC (MTP.OQ)
MTP.OQ on NASDAQ Stock Exchange Capital Market
Change (% chg)
Revenue & Earnings Per Share
Consensus Estimates Analysis
No consensus analysis data available.
Performance for Midatech Pharma PLC
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Midatech Pharma Says Approval Of Investigational New Drug Application From US FDA To Conduct Study Of MTX110
- BRIEF-Midatech Pharma Enters Into Four-Year Senior Secured Loan Agreement With Midcap Financial Of Up To $15 Mln
- BRIEF-Midatech Pharma U.S. Initiates Gelclair Phase IV Trial To Study Oral Mucositis In Stem Cell Transplant Patients
- BRIEF-Midatech Pharma announces proposed placing and open offer
|% Shares Owned:||0.21%|
|# of Holders:||5|
|Total Shares Held:||55,613|
|3 Mo. Net Change:||0|
|# New Positions:||0|
|# Closed Positions:||0|
|# Increased Positions:||0|
|# Reduced Positions:||0|
|# Net Buyers:||0|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.